Business
CSL (ASX:CSL) share price on watch after hints of ‘far more robust’ vaccine – The Motley Fool Australia
Australian global biotech giant, CSL Limited didn’t win the sprint for a coronavirus vaccine. But it may lead the marathon.
The CSL Limited(ASX: CSL) share price is edging higher today, up 0.2% in afternoon trading.
That’s broadly in line with the wider S&P/ASX 200 Index (ASX: XJO), up 0.4% at time of writing.
With a history of generally delivering fairly steady share price growth, 2020 has been unusually volatile for CSL shareholders. While there are various reasons for this, traders jumping in and out of shares based on the latest COVID-19 vaccine news have certainly helped stir this year’s share price volatility.
…
-
Noosa News23 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General18 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General20 hours agoReason v magical climate thinking – voters have no choice
-
General17 hours agoPope Francis appears Easter Sunday to deliver blessing as recovery continues